# BetaLACTA® Test for Early De-escalation of Empirical Carbapenems in Pulmonary, Urinary and Bloodstream Infections in ICU

> **NCT03147807** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 75 (actual)

## Conditions studied

- Pneumonia
- Urinary Tract Infections
- Bloodstream Infection

## Interventions

- **DEVICE:** betaLACTA® rapid diagnostic test

## Key facts

- **NCT ID:** NCT03147807
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-20
- **Primary completion:** 2019-09-21
- **Final completion:** 2019-10-20
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2022-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03147807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03147807, "BetaLACTA® Test for Early De-escalation of Empirical Carbapenems in Pulmonary, Urinary and Bloodstream Infections in ICU". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03147807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*